Skip links

Injectable

Compounded Injectable Medication for Weight Management

The usage of GLP-1 and GIP receptor agonists has grown worldwide. This class of medication includes several different injectable medications, Semaglutide and Tirzepatide. High demand has pushed these medications onto the FDA’s Drug Shortage List. As a result, the FDA has issued guidance for compounding pharmacies to help address the shortage by making essential copies of the patented drugs, for as long as the drugs remain on the FDA’s Shortage List. 

Prescribers Click Here to Request More Information

HOW DO THESE MEDICATIONS WORK?

GLP-1 and GIP receptor agonists work by increasing the amount of insulin that the pancreas releases in response to food, while decreasing the amount of sugar the liver releases into the blood and slows food leaving the stomach after eating. This in turn helps control blood glucose levels and prompts the feeling of fullness, resulting in weight loss overtime. These medications are intended to work in conjunction with diet and exercise to improve blood sugar (glucose) levels in adults with type 2 diabetes mellitus. These medications are not for use in patients with type 1 diabetes.

WHY POTTER’S HOUSE APOTHECARY?

Trust is key when you are working with a compounding pharmacy to provide you with a high-risk, sterile medication. In addition to our voluntary PCAB Accreditation, our pharmacy is USP 795, 797, and 800 compliant. We use high quality ingredients from FDA registered facilities and leverage state-of-the-art technology to produce medications that meet your healthcare provider’s exact specifications. We send our sterile preparations to an independent lab for sterility and potency testing to validate our process and ensure the safety and quality of the medications we dispense. You will have peace of mind knowing that your medication has been compounded by a trusted pharmacy professional and is not only safe, but effective.

Prescribers Click Here to Request More Information